Got a Question?
If you have a question for our guest, host or DRG please submit it here.
Securing investments amidst COVID-19 and Brexit uncertainties
Guest: Hakan Goker, Vice President, M Ventures
In this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG talks to Hakan Goker, Vice President of M Ventures. Hakan gives a unique insight into how both COVID-19 and Brexit are affecting current investment opportunities for both investors and start-ups, including restrictions on travel, face to face pitching and pipeline requirements. He talks about the increasing importance on making sure all written communications and presentations are clear and sharp in this era to help executives secure and access finance, as well as patience while VC’s focus on existing partnerships. Hakan also gives an overview of the benefits of work with corporate VC’s, such as M Ventures, and how they minimize cross-contamination with the biotech and their pharma company. Listen to the full interview here.
About our Guest
Sanjay Kakkar, CEO, Tranquis Therapeutics
Hakan Goker (Ph.D.) is Vice President and responsible for healthcare investments at M Ventures, corporate venture arm of the biopharmaceutical division of Merck KGaA, Darmstadt, Germany. Hakan has been investing for the past 14 years as a partner at Aescap Venture and prior to that as part of Atlas Venture life sciences team, joining M Ventures in 2013. Since 2006, Hakan has been instrumental in the creation, financing, and corporate strategy of multiple biotechnology companies globally including Artios, Asceneuron, Ribometrix, Storm, Bicycle, and F-star.
About our Host
Mike Ward, Head of Thought Leadership, DRG
Mike Ward serves as Global Head of Thought Leadership at Decision Resources Group (DRG), part of Clarivate. As both a journalist and analyst, Mike has been writing, analyzing and commenting on the life sciences industry for more than 35 years. He has held editorial and content leadership roles at various publications and organizations across the industry.
